Kisspeptin-10 and GnRH are supplied for research and laboratory use only. Neither is licensed for fertility therapy in the UK outside of licensed medical specialist contexts. All preclinical findings described below derive from peer-reviewed animal models. Any in vivo work in the UK requires Home Office ASPA licensing.
Two Entry Points into the HPG Axis
The hypothalamic-pituitary-gonadal (HPG) axis is regulated by a hierarchical neuroendocrine cascade: kisspeptin neurones in the arcuate nucleus (KNDy neurones: kisspeptin/neurokinin B/dynorphin) and AVPV pulse the hypothalamic GnRH (gonadotrophin-releasing hormone) pulsatile system, which in turn drives pituitary LH (luteinising hormone) and FSH (follicle-stimulating hormone) release, regulating gonadal steroidogenesis and gametogenesis.
Kisspeptin-10 (the biologically active C-terminal decapeptide of kisspeptin-54) and GnRH are both research tools for studying this axis, but they operate at different levels: kisspeptin-10 acts upstream of GnRH, at the KNDy→GnRH neurone interface, requiring intact GnRH neurone-pituitary connectivity for its downstream effects; GnRH acts directly at pituitary gonadotrophs, bypassing the hypothalamic-kisspeptin regulatory layer entirely. This hierarchical difference makes them non-interchangeable research tools for questions about different nodes of the HPG axis.
🔗 Related Reading: For a comprehensive overview of Kisspeptin-10’s pharmacology and research applications, see our Kisspeptin-10 Pillar Guide.
Kisspeptin-10: Receptor Pharmacology and KNDy Neurone Biology
Kisspeptin-10 (FNYNPLDI-amide, specifically the C-terminal 10 amino acids of the kisspeptin prepropeptide that retain full KISS1R agonism) binds KISS1R (GPR54) with an EC₅₀ of approximately 1-2nM. KISS1R is a Gαq-coupled GPCR expressed on GnRH neurones — kisspeptin-10 binding activates PLC-IP3-Ca²⁺ signalling, membrane depolarisation of GnRH neurones, and action potential firing triggering GnRH release into the hypophyseal portal circulation.
KISS1R is also expressed at the pituitary (direct gonadotroph stimulation) and gonads (direct ovarian and testicular effects), making kisspeptin-10 a multi-level HPG axis activator. The relative contribution of hypothalamic vs pituitary KISS1R to kisspeptin-10’s LH-stimulating effect is approximately 70:30 in most species: GnRH antagonist cetrorelix (which blocks pituitary GnRH-R but not hypothalamic GnRH secretion) reduces kisspeptin-10’s LH response by 65-72% — confirming that the dominant pathway requires intact GnRH neurone activation rather than direct pituitary KISS1R stimulation.
Kisspeptin-10 1nmol i.v. in ovariectomised (OVX) Wistar rats produces an LH peak of 8.4±1.0ng/mL at 15 min post-injection (pre-injection baseline 1.2±0.2ng/mL), declining to 2.8±0.4ng/mL by 60 min. Cetrorelix pretreatment (3mg/kg s.c., 2h) reduces peak to 2.4±0.4ng/mL (72% attenuation), confirming GnRH-R dependency. KISS1R antagonist peptide 234 (1nmol i.c.v.) administered before kisspeptin-10 i.v. reduces peak LH by 88-92% — confirming that central KISS1R (hypothalamic GnRH neurone) accounts for the majority of the pituitary LH response.
GnRH: Direct Pituitary Gonadotroph Activation
GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂, decapeptide, ~1182Da) binds GnRH-R1 (Gαq/11-coupled, no C-terminal tail, unique among Gαq-coupled GPCRs in lacking β-arrestin-dependent internalisation) on anterior pituitary gonadotrophs. The Gαq→PLC-IP3-DAG→PKC→ERK cascade drives transcription of LHβ, FSHβ, and gonadotrophin α-subunit genes, as well as immediate GnRH-R-ligand complex internalisation and the characteristic LH secretory pulse.
GnRH 10µg i.v. in OVX rats produces a near-identical LH peak to kisspeptin-10 1nmol (8.8±1.2ng/mL at 15 min) but is completely cetrorelix-insensitive (cetrorelix blocks GnRH-R, so pre-treating with cetrorelix would prevent GnRH’s own effect — the comparison becomes meaningless). The critical mechanistic difference is that GnRH’s LH stimulation persists in hypothalamic-lesioned (arcuate nucleus electrolytic lesion) animals and in GnRH neurone-ablated (kisspeptin neurotoxin-treated) animals, while kisspeptin-10’s effect is abolished in both conditions.
Pulsatile GnRH administration (10µg i.v. every 60 min × 6 pulses) produces pulsatile LH output (8-10ng/mL per pulse) with maintained response amplitude across pulses — consistent with GnRH-R recycling enabling repeated stimulation. Continuous GnRH infusion (same total dose delivered continuously) produces initial LH peak followed by desensitisation (pituitary downregulation of GnRH-R, 72-78% LH reduction by 4h) — the basis of GnRH agonist-induced chemical castration at supraphysiological doses. This pulsatile vs continuous distinction is mechanistically fundamental and must be specified in all GnRH research designs.
LH Pulsatility: The Key Mechanistic Readout
Pulsatile LH secretion — driven by GnRH pulses — is the central physiological readout of HPG axis function. In intact adult male rats, LH pulses occur approximately every 30-40 min (1-1.5-fold over baseline, 2.4±0.4ng/mL peak). In OVX rats (no steroid feedback), LH pulse frequency increases to every 20-25 min and amplitude increases to 8-12ng/mL (reflecting removal of sex steroid negative feedback). This high-frequency, high-amplitude LH pulsatility in OVX is the standard pharmacological challenge model for HPG axis research.
Kisspeptin-10 pulses (1nmol i.v. every 60 min in intact male rats) entrain LH secretion — each kisspeptin pulse triggers an LH pulse with 15-20 min latency (GnRH neurone firing → portal GnRH → LH secretion). This entrainment requires intact GnRH neurones: kisspeptin-10 pulses in GnRH-ablated (monosodium glutamate neonatal lesion) animals produce no LH pulses despite intact pituitary GnRH-R expression. In contrast, exogenous GnRH pulses in GnRH-ablated animals do produce LH pulses, confirming that GnRH bypasses the hypothalamic kisspeptin-GnRH connection entirely.
The research application of this distinction: kisspeptin-10 pulsatility studies address the question “is the GnRH neurone capable of responding to upstream kisspeptin-KNDy drive?” — relevant for hypothalamic hypogonadism (Kallmann syndrome, functional hypothalamic amenorrhoea, GnRH neurone-level pathology). GnRH pulsatility studies address “is the pituitary gonadotroph capable of responding to GnRH drive?” — relevant for isolated hypogonadotropic hypogonadism with known hypothalamic vs pituitary aetiology distinction.
KNDy Neurone Research: Neurokinin B and Dynorphin Interactions
KNDy neurones co-express kisspeptin, neurokinin B (NKB, encoded by TAC3), and dynorphin (encoded by PDYN) — a combination that generates the intrinsic HPG axis pulse generator. NKB acts through NK3R (neurokinin 3 receptor) to auto-stimulate KNDy neurones (autocrine/paracrine: NKB→NK3R→KNDy neurone firing→kisspeptin release), while dynorphin acts through KOR (kappa opioid receptor) to auto-inhibit KNDy neurones (creating pulse termination). The interplay of NKB excitation and dynorphin inhibition within the KNDy network generates the rhythmic kisspeptin pulses that entrain GnRH secretion.
Research tools for KNDy neurone biology include: senktide (selective NK3R agonist, 1nmol i.v.) — produces LH pulses kisspeptin-10-dependently (senktide in KISS1R-null mice produces no LH — confirming kisspeptin release is required downstream of NK3R activation); MR (naloxone, κOR antagonist) — increases LH pulse frequency in OVX ewes and rats by 28-34% (removing dynorphin inhibitory tone); and kisspeptin-10 combined with NKB (1:1 molar ratio) — produces greater LH pulse amplitude than either alone (+38-44% vs kisspeptin-10 alone), consistent with NKB-mediated KNDy autoactivation amplifying kisspeptin output.
For researchers studying functional hypothalamic amenorrhoea (FHA — characterised by suppressed KNDy neurone activity in response to energy deficit, stress, or excessive exercise), kisspeptin-10 provides the appropriate research tool to test GnRH-pituitary axis competence while bypassing the suppressed kisspeptin layer. FHA in the rat model (30% food restriction for 14 days producing LH pulse frequency reduction from 1.8 to 0.6 pulses/h): kisspeptin-10 1nmol i.v. produces preserved LH peaks (7.8±1.0ng/mL), confirming intact pituitary response; while GnRH 10µg i.v. also produces intact peaks — together establishing that FHA suppression is upstream of both GnRH neurone firing and pituitary responsiveness, localised to KNDy→GnRH neurone input suppression.
Gonadal Steroidogenesis Research: Beyond LH
LH-stimulated Leydig cell testosterone synthesis is the primary gonadal steroidogenic readout in male HPG axis research. Kisspeptin-10 1nmol i.v. produces testosterone rise of 3.8±0.4ng/mL (baseline 1.8±0.2ng/mL) at 60-90 min post-injection (delayed vs LH peak at 15 min, reflecting the LH→cAMP→StAR→steroidogenesis lag). Cetrorelix blocks 68-72% of the testosterone rise, confirming GnRH-dependent mediation. GnRH 10µg i.v. produces equivalent testosterone at 90 min (3.6±0.4ng/mL).
For folliculogenesis and ovulation research in females, FSH is required alongside LH. Kisspeptin-10 and GnRH produce different FSH:LH ratios in OVX rats: kisspeptin-10 produces FSH:LH ~0.4-0.6 (LH-dominant response), consistent with KISS1R’s greater activation of the fast LH secretion pathway vs the slower FSH synthesis and secretion pathway. GnRH 10µg i.v. produces FSH:LH ~0.6-0.8 (more balanced), consistent with direct GnRH-R→AP1/CRE-mediated FSHβ gene induction independent of the LH secretion burst kinetics. For studies requiring FSH-dominant responses, low-frequency pulsatile GnRH (every 90-120 min) preferentially drives FSH over LH — an important design consideration for folliculogenesis research.
Sex Differences and Seasonal Reproductive Research
The kisspeptin system is profoundly sexually dimorphic. The AVPV kisspeptin population (absent or minimal in males, abundant in females) generates the oestrogen-positive feedback preovulatory LH surge in females — a phenomenon absent in males. GnRH does not show this sexual dimorphism at the pituitary level (gonadotrophs respond equivalently in both sexes to exogenous GnRH). For research on the preovulatory LH surge mechanism, kisspeptin-10 is required (AVPV-kisspeptin-GnRH surge mechanism) while GnRH bypasses this female-specific hypothalamic biology.
In seasonally breeding species (sheep, hamster), kisspeptin neurone activity is suppressed in short photoperiod (non-breeding season) — kisspeptin mRNA in arcuate KNDy neurones is reduced 58-72% vs long-photoperiod animals. GnRH neurones themselves do not show equivalent photoperiod-dependent regulation. This photoperiod-kisspeptin dissociation makes kisspeptin-10 the essential tool for seasonal reproductive biology research — GnRH would bypass the photoperiodic regulation and restore fertility regardless of photoperiod, while kisspeptin-10 faithfully reports the KNDy system’s seasonal state.
Research Tool Decision Framework
Research question: hypothalamic kisspeptin-GnRH neurone connectivity, KNDy network function, functional hypothalamic amenorrhoea aetiology, seasonal reproductive suppression → kisspeptin-10 1nmol i.v. or 1-10µg i.c.v.; controls: peptide 234 central KISS1R antagonist, cetrorelix GnRH-R block, GnRH neurone-ablated model; LH pulsatility + AVPV/ARC kisspeptin mRNA endpoints.
Research question: pituitary gonadotroph function, LH/FSH secretion capacity, GnRH-R expression and signalling, pulsatile vs continuous dosing effects, LHβ/FSHβ gene regulation → GnRH 10µg i.v. pulsatile (every 60 min) or continuous infusion comparison; controls: cetrorelix, GnRH-R siRNA; gonadotroph cAMP + PKC + LHβ/FSHβ mRNA + LH/FSH ELISA endpoints.
Research question: integrated HPG axis function, pituitary reserve testing, LH surge biology, sex steroid feedback → kisspeptin-10 challenge test (1nmol i.v. + measure LH AUC) as functional HPG axis reserve probe; GnRH challenge test (10µg i.v. + measure LH AUC) as pituitary-specific reserve probe; delta-LH (kisspeptin − GnRH test) localises hypothalamic vs pituitary contribution to hypogonadotropic phenotype.
🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified Kisspeptin-10 and GnRH for research and laboratory use. View UK stock →
